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a b s t r a c t 
Background: Drug-related deaths globally are increasing year on year, with the largest proportion of these being 
opioid-related. The opioid antagonist naloxone distributed for take-home use (‘Take-Home Naloxone (THN)’) has 
been championed as one method of tackling this public health crisis, however to be effective it must be available 
at an opioid overdose. Ownership and carriage are therefore fundamental to THN success. This study aimed to 
assess the prevalence of ownership and carriage of THN internationally among people who use drugs (PWUD). 
Methods: NHS Scotland Journals, AMED, EMBASE, HMIC, MEDLINE, PsycINFO, CINAHL Complete, PubMed, 
Cochrane Library, PROSPERO and grey literature were searched for articles which measured prevalence of THN 
ownership or carriage between 1996 and 2020. Ownership was defined as report of a personal supply of THN. 
Carriage was defined as the participant carrying THN on their person at time of data collection or reporting 
a frequency of how often they carry THN. Risk of bias was evaluated using the Joanna Briggs Checklist for 
Prevalence Studies. 
Results: Systematic search yielded 6363 papers, with ten eligible papers identified. Eight articles were included 
in ownership prevalence and five articles included for carriage prevalence, with an overlap of three studies 
between both measures. Pooled prevalence indicated moderate ownership levels (57%, CI 47-67%) but lower 
carriage levels (20%, CI 12-31%). Analysis was complicated by the limited number of available studies and lack 
of standardised terminology and measurement. 
Conclusion: Understanding naloxone ownership and carriage globally is hampered by limited evidence and het- 
erogeneity across studies. From the available data, prevalence of THN carriage overall appears low, despite 
moderate ownership. Given the variation across studies, future research should seek to utilise more standardised 
terminology and methods of measurement. Furthermore, services distributing THN must ensure the importance 





























Across the globe, the impact of problematic opioid use is increas-
ng. Rising drug-related death rates are being seen in the UK, USA, parts
f Africa, and South-East Asia, the majority of which are attributed to
pioids due to overdose ( UNODC, 2020 ). According to the United Na-
ions World Drug Report (2020), 66% of an estimated 167,000 deaths
elated to drug use disorders worldwide were due to opioids, using
ost recent available data. Given these premature, highly preventable
eaths, there is a growing need to identify and implement effective in-
erventions. Consequently, the opioid antagonist naloxone, distributed
or take-home use, has been progressively championed as one method of∗ Corresponding author. 
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(THN) ownership and carriage, International Journal of Drug Policy, https:/ackling drug-related deaths (DRD) ( Strang et al., 2014 ). Distribution of
aloxone for use at home by lay people or people who use drugs (PWUD)
hrough peer administration (‘Take-Home Naloxone (THN)’) has signif-
cantly strengthened internationally since early initiatives in the 1990s
 McDonald and Strang, 2016 ). 
The majority of THN studies to date have assessed distribution or
ffectiveness of THN programmes and have indicated significant im-
act on rates of opioid overdose deaths ( McDonald and Strang, 2016 ;
alley et al., 2013 ). Despite findings which indicate the potential of
HN in preventing fatalities, overdose remains a major cause of prema-
ure mortality in the developed world ( EMCDDA, 2020 ). It is important
o assess what may facilitate or prevent the optimal use of naloxone.
obin et al. (2018) refer to the naloxone ‘cascade of care’ which out-
ines the five phases they suggest are required for optimal THN use: 
1. awareness of THN; 
2. access to a supply; article under the CC BY-NC-ND license 
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p  3. training in use; 
4. use in an overdose situation; 
5. possession meaning carriage on the person and the frequency of this.
There has been a significant research focus on awareness, sup-
ly, and training in THN use, with increasing interest in its use in
n overdose situation ( Bennett & Holloway, 2012 ; Giglio et al., 2015 ;
cAuley et al., 2015 ; Nolan et al., 2017 ). Whilst naloxone awareness,
ccess, and training are essential, they are insufficient in themselves to
nsure optimal overdose prevention outcomes: there is the additional
eed for availability during overdose situations ( Tobin et al., 2018 ). As
 result, the aim of this study was to assess the prevalence levels of
wnership and carriage of THN internationally among people who use
rugs. In order to achieve this a systematic review of the literature was
onducted and the results were subjected to meta-analysis. 
ethods 
We have used the term ‘carriage’ within this paper, rather than To-
in’s term of ‘possession’, because there is ambiguous use of “possession ”
ithin the literature. Historically possession has been used within dif-
erent studies to signify both carrying naloxone on one’s person, as well
s simply owning or receiving naloxone. This imprecision can lead to
mbiguity in measuring these different constructs. Someone may have
received’ naloxone but no longer own or carry it, and they may ‘own’
aloxone but never carry it, yet, because of this ambiguity, they may
ll be deemed to ‘possess’ it. For this study, the terms of interest were
wnership and carriage of naloxone which were defined as follows: 
• ownership: the participant reported a personal supply of THN (e.g.
at home or other easily accessible place); 
• carriage: the participant carried THN on their person at time of data
collection OR reported a frequency of how often they carry THN on
their person. 
ligibility criteria 
This research focused on PWUD who engage with harm reduction or
ealth services on this basis. This population is used in comparison to
hose who may be perceived to use substances recreationally, or who
ngage with statutory services for prescribed medications on a short-
erm basis for an acute problem. We recognise that there may be some
verlap between these groups, as those who receive prescribed medi-
ations may augment with illicit substances, however, they would only
e included in this study if they engaged with services specifically due
o an issue linked to their substance use. The inclusion criteria were as
ollows: 
• study population must include PWUD, or who have formerly used
drugs, and who engage with harm reduction or health services on
this basis, people deemed to be at risk of opioid overdose, and PWUD
who are likely to witness overdose; 
• study designs must be observational, but may include cohort studies,
cross-sectional studies, case-control studies, surveys; 
• studies must include outcome measures of carriage or ownership lev-
els observed. 
Exclusion criteria included: 
• studies reporting solely qualitative analyses; 
• ownership of naloxone by first responders/law enforcement or other
professional care providers rather than by PWUD in a ‘take-home’
capacity; 
• ownership/carriage by family members of PWUD, who themselves
do not use drugs; 
• ownership of naloxone by specific population groups (e.g., in preg-nancy). i  
2 earch strategy and information sources 
A comprehensive literature search was conducted through NHS Scot-
and Journals, AMED, EMBASE, HMIC, MEDLINE, PsycINFO, CINAHL
omplete, PubMed, Cochrane Library and PROSPERO. Grey literature
earches were undertaken via Google and Ovid (conference proceed-
ngs). Hand searches of relevant contents pages within selected journals
nd the reference sections of relevant articles were also conducted. In
ddition, authors in the field of harm reduction and take-home nalox-
ne were contacted via email to ascertain whether any further literature
xisted that reviewers had not gleaned via formal search. Search struc-
ure and terms were discussed with an experienced information special-
st, then conducted by two investigators (GB, JS). The following search
erms were used: 
1. (Naloxone OR Narcan OR Prenoxad OR Evzio) AND 
2. (‘Take home’ OR ‘Take-home’) AND 
3. (Overdose OR ‘Drug-related death’) 
nder ‘all-text’ searches where applicable. Searches were not combined
ith ‘AND’ for Cochrane Library or PROSPERO because search returns
ere too small to ensure adequate coverage when terms were combined.
or this reason, three separate searches with the above three groups of
erms were conducted for these databases and results pooled. Searches
ere limited to those articles published between January 1996 and April
020. This date range was chosen as it best reflects the years during
hich THN has been most actively implemented within national pro-
rammes. The range was set as intentionally wide in order to ensure
hat relevant information was not missed, for example to identify poten-
ial serial analysis which may have initially published early but which
ay have more up to date data available unpublished (the reference for
hich might be missed by narrowing the search too early in the pro-
ess). In the instance of serial analyses, the most recent available data
as used. Language was not used as a formal search criterion. 
A search report was created with all identified titles captured in Re-
Works or Mendeley ( Table 1 ). Reviewers (GB, JS) then removed dupli-
ates and conducted initial screening independently. Abstracts and full
ext articles were assessed for eligibility then results compared to pro-
ide quality assurance. Discussions took place regarding which papers
o include within the review and consensus reached between authors
GB, JS, AM) regarding the papers to be included, without the need for
rbitration. 
ata extraction and analysis 
Data extraction was undertaken by two reviewers independently
GB, AY) and results compared, according to the agreed upon defini-
ions. The study aim was to assess regular carriage, therefore, for those
apers that did not directly measure or define ‘regular’ carriage, for ex-
mple those using a frequency breakdown, it was important to define
hat frequency of carriage was consistent enough to be deemed regu-
ar. Where necessary, email contact was made with authors of eligible
apers to clarify definitions or information provided, and/or to request
aw data. It was agreed that measures of ‘often/always’, ‘regular’, and
on the day of interview’, were all measures which were sufficiently reg-
lar for the numbers reporting this level of carriage to be used in the
ooled analysis. As a result, study respondents who reported ‘rarely’,
sometimes’, or other occasional carriage, were not included within the
ooled analyses, as these reported levels were classed as too infrequent.
he rationale for measuring regular carriage is to measure maximum
ccessibility, as those who carry THN more regularly have the greatest
otential for using it. To explore the effect of “carriage on the day of
nterview ” on carriage prevalence, studies which measured this were
xcluded in one subgroup analysis for carriage. Ownership data was
ooled in three ways according to the time period of ownership spec-
fied by each study: 1. ownership of naloxone at any point; 2. current
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Table 1 
Search strategy: search terms utilised and results. 
Search Terms Year 
limits applied from 
beginning of search 
Number of Articles 
Group One – Ovid NHS 
Scotland Journals AMED 
Embase HMIC Medline APA 
PsycINFO 1996 - 2020 
CINAHL Complete 
Jan 1996 to April 
2020 All text 





Cochrane Library pub 
date Jan 1996 to April 
2020 All text 
1 Naloxone OR 
Narcan OR 
Prenoxad OR Evzio 
Multifield Search, all fields 
(Naloxone or Narcan or 
Prenoxad or Evzio).af. 
57834 
TX Naloxone OR 
Narcan OR 
Prenoxad OR Evzio 
7828 
All fields: ("naloxone"[MeSH 
Terms] OR "naloxone"[All 
Fields] OR "naloxone"[MeSH 
Terms] OR "naloxone"[All 
Fields] OR "narcan"[All Fields] 
OR "evzio"[All Fields] OR 
"naloxone"[MeSH Terms] OR 
"naloxone"[All Fields]) AND 
(1996/1/1:2020/4/12[pdat]) 
16420 
56 Reviews: 71 
Protocols: 5 
Trials: 2541 
Clinical Answers: 10 
Total: 2627 
2 ‘Take home’ OR 
‘Take-home’ 
Multifield Search, all 
fields: (Take home or 
Take-home).af. 16246 
TX "Take home ”
OR “Take-home ”
11342 








Clinical answers: 1 
Total: 696 
3 Overdose OR 
‘Drug-related 
death’ 
Multifield Search, all 
fields: (Overdose or 
"drug-related death").af. 
86475 
TX Overdose OR 
“Drug-related 
death ” 22936 
All fields: ("drug 
overdose"[MeSH Terms] OR 
("drug"[All Fields] AND 
"overdose"[All Fields]) OR 
"drug overdose"[All Fields] OR 
"overdose"[All Fields] OR 
"overdoses"[All Fields] OR 
"overdosed"[All Fields] OR 





136 Reviews: 187 
Protocols: 17 
Trials: 1426 
Special collections: 1 
Clinical answers: 8 
Total: 1639 
1 + 2 + 3 all fields 
OR 
Total of 3 searches 
(PROS- 
PERO + Cochrane) 


























































N  wnership (defined as currently having a personal supply at time of data
ollection); 3. ownership within the last 12-month period. 
tudy quality assessment 
The JBI critical appraisal instrument for studies reporting prevalence
ata tool was utilised by one reviewer (GB) ( Munn et al., 2015 ). This pro-
ides an overall analysis of quality and an insight into risk of bias within
he context of studies specifically focusing on prevalence data, given
hat the context and bias profiles of these are unlike those of other non-
andomised research designs ( Joanna Briggs Institute, 2014 ). Where no
esponse rate or sample size calculation was given, a standard sample
ize calculation was used for comparison, using the following formula by
aing et al. (2006) and the conventions of 95% confidence interval, 20%
xpected prevalence, and 5% precision: 𝑛 = 𝑍 
2 
𝑃 ( 1− 𝑃 ) 
𝑑 2 
. Considering that
uch of the data for this research was found in peer-reviewed journals,
here is a high potential for publication bias. We attempted to minimise
his by making direct contact with authors and professionals in the harm
eduction field, and by performing grey literature searches, to glean ev-
dence which may exist outside formal publication. An overall quality
ssessment and risk of bias was made for each paper which can be seen
n Supplementary Table 1. Funnel plots were also created to assess risk
f reporting bias (Supplementary Figs. 1 and 2). 
tatistical analysis 
When combining results from observational studies, heterogene-
ty of design, population and outcome is generally anticipated
 Stroup et al., 2000 ). We assessed heterogeneity using both descriptive3 nalysis and the I 2 statistic to quantify the extent that variability across
tudies was due to heterogeneity and not due to random sampling. The
onvention of I 2 over 75% indicating high heterogeneity was utilised.
ata was presented graphically using forest plots. Meta-analysis was
ndertaken using a random-effects (DerSimonian and Laird) model to
ccount for heterogeneity and was performed using the MetaXL add-
n for Microsoft Excel ( www.epigear.com ). Pooled prevalence figures
ere calculated with 95% confidence intervals, and appropriate sub-
roup analyses conducted to explore possible causes of heterogeneity
nd robustness of results. To address variance instability, the Freeman-
ukey double arcsine transformation was applied to pooled prevalence
stimates ( Barendregt et al., 2013 ). Statistical analyses were undertaken
y two authors (GB, AY) to ensure accuracy of results. 
esults 
earch results 
Database searches resulted in a total of 6363 papers being identified.
 further 17 papers or reports were identified via grey literature search,
and search, or direct author contact, and included one paper submitted
or publication. Following removal of duplicates, 4469 papers remained.
hilst language was not used as a formal search criterion, the authors
id not find any papers which contained relevant data that had not been
ublished in the English language. To minimise overlap of sampling pop-
lations, or due to study design or quality, nine studies were discounted
rom the ownership analysis ( Buresh et al., 2020 ; Davis et al., 2016 ;
lick et al., 2017 ; Lopez Gaston et al., 2009 ; Marco et al., 2018 ;
olan et al., 2017 ; Schneider et al., 2019 ; Tobin et al., 2018 ). Five
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p  tudies initially reviewed for carriage analysis were also discounted
 Buresh et al., 2020 ; Lopez Gaston et al., 2009 ; Parmar et al., 2017 ;
obin et al., 2018 ; UAM 2019 ), due to study design, quality, or overlap
f sample populations. Additional information on the search results are
rovided within the PRISMA diagram ( Fig. 1 and Table 1 ). 
tudy characteristics 
Whilst the search criteria allowed for several study designs, all even-
ual eligible studies were cross-sectional analyses with validated mea-
ures. These were included if prevalence of ownership or carriage were
resented or could be calculated from the data provided. Study popu-4 ations ranged from 72-2130 respondents, with countries of origin in-
luding the US (five papers), Canada (two papers), the UK (two papers),
nd Europe (one paper). Drug use status ranged from study populations
eing asked whether they had used substances within the past 30 days,
p to use within the past 12-month period. A fuller summary of study
haracteristics can be seen in Table 2 . Eight papers met the criteria for
nclusion within the ownership analysis. For the carriage analysis, four
tudies met the criteria, with a further study obtained through direct au-
hor communication, giving a total of five articles. Three articles are in-
luded within both analyses ( Dayton et al., 2019 ; Khatiwoda et al., 2018 ;
ealth Protection Scotland, 2019 ). The 10 included studies measured




































































































Summary of included studies. 
Study 
Sample 
Size Sample Age Ethnicity Gender 
% treatment 
receipt ∗∗ 
% injection drug 





Allen et al., 2019 371 Mean 35.8 White 83.4% Female: 40.4% 
Male: 59.6% 
N/A 88.7% West Virginia, US In the past 6 months, 
did you get Narcan or 
naloxone to carry with 
you? 
179/371 48% 




60% 97% Washington State, 
US 
At any time in the past 
3 months, have you 
had a naloxone/ 
Narcan kit? 
915/1265 72% 
Dayton et al., 2019 577 Mean 47 + /-11 N/A ∗ Female: 34% 
Male: 66% 
63% 63% Baltimore, US Have you ever been 
prescribed or received 
a kit containing 
Narcan? 
380/577 66% 
Goldman-Hasbun et al., 
2017 
177 Median 22.2 
IQR 20.2, 23.4 
White: 54.8% Female: 38.4% 
Male: 61.6% 
55.9% a 38.4% b Vancouver, B.C, 
Canada 
Do you currently own 
a THN rescue kit? 
40/177 23% 
Health Protection Scotland, 
2019 
2130 Mean 40.6 
Median 40.2 
N/A Female: 27% 
Male: 73% 
Last 6 months: 
56.3% 
Last 6 months: 69% Scotland Have you been 
prescribed take-home 
Naloxone in the past 
year? 
1299/2130 61% 
Khatiwoda et al., 2018 100 Inclusion > 18 yrs 
No other ref made 
White: 90.8% Female: 58% 
Male: 42% 
N/A N/A North Carolina, US Have you ever gotten a 
Kit for yourself? 
74/100 74% 
Madah-Amiri et al., 2019 497 Mean 44.9 N/A Female: 24.5% 
Male: 75.5% 
51.1% 72.4% Norway Do you have naloxone? 188/497 38% 
Moustaqim-Barrette et al., 
2019 
348 Median 40 
IQR 32, 49 
First nations: 24.7% 













Dayton et al., 2019 345 Mean 47 + /-11 N/A ∗ Female: 34% 
Male: 66% 
63% 63% Baltimore, 
Maryland, US 
How often do you 
carry Narcan with 
you? 
31% often/always 
Health Protection Scotland, 
2019 
1299 Mean 40.6 
Median 40.2 
N/A Male: 73% 
Female: 27% 
Last 6 months: 
56.3% 
Last 6 months: 69% Scotland Are you carrying any 
naloxone with you 
today? 
13% carriage on 
day of interview 
Khatiwoda et al., 2018 72 Inclusion > 18 yrs 
No other ref made 
White: 90.8% Female: 58% 
Male: 42% 
N/A N/A North Carolina, US How often do you 




McDonald et al., 2020 131 Mean range 25-44 N/A Female: 26.3% 
Male: 73.7% 
N/A N/A Results from 
London/ 
Birmingham 
Are you carrying any 
naloxone with you 
today? 
8% carriage on day 
of interview 
Reed et al., 2019 571 Median 35 







56.3% Philadelphia, US Do you carry Narcan? 12% regular 
carriage 
∗ N/A refers to a study making no reference to the inclusion of this data. 
∗∗ the widest time periods for measurement of receipt of treatment was in the past 12-month period. 
∗∗∗ the widest time period for measurement of injection drug use was in the past 12-month period. 
a ( Goldman-Hasbun et al., 2017 ) refers more broadly to ‘Drug and Alcohol treatment’. 
b ( Goldman-Hasbun et al., 2017 ) refers to public injecting only. 
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Fig. 2. Forest plot - Ownership pooled prevalence estimate. 

























































d  iage. Time periods for ownership studies varied from current ownership
t time of data collection (three studies), ownership within the previous
, 6 or 12 months (three studies), or ownership at any time (two stud-
es). Three of the carriage papers measured total regular carriage, either
y measuring carriage on the day of data collection, or by asking about
egular carriage, and two provided a frequency breakdown of carriage
often/always, sometimes/mostly, never/rarely). All studies used struc-
ured questionnaires completed on paper or electronically, with data
aptured either by a researcher during face-to-face interviews (seven
tudies), or through participant self-completion (two studies). One fur-
her study used mixed data collection methods involving face-to-face
nterviews for demographic and other information, with computerised
elf-completion for what was deemed ‘sensitive risk behaviour data’
 Dayton et al., 2019 , p3). 
Participants were generally recruited in one of two ways. The first
ethod used harm reduction or medical treatment sites, such as addic-
ion services, injection equipment providers, drug treatment centres, or
ommunity pharmacies, which we have termed ‘fixed site’ sampling.
he second approach we have termed ‘mobile/outreach’ and includes
hose studies which undertook street-based sampling at known high use
reas, or via agencies who work with PWUD on the street, which gen-
rally resulted in respondent driven or snowball sampling procedures. 
The JBI nine-point critical appraisal tool was used to assess studies in
erms of their sampling methods, size, demographics, coverage, validity
nd standardisation, statistical methods, and response rate. Based on
aing et al’s (2006) , formula the estimated adequate sample size rate
ould be 246 responses, therefore any study with a sample over this
as deemed to have an adequate response level. The main risks in the
ncluded studies were non-random sampling methods (convenience or
nowball sampling), recruitment from non-representative samples (e.g.
olely from medication-assisted treatment (MAT) clinics), small sample6 izes, and high risk of inherent response/recording bias (mostly due to
ata collection method). A formal assessment of study quality can be
een in Supplementary Table 1. An assessment of reporting bias can
e observed for ownership in Supplementary Fig. 1 and for carriage in
upplementary Fig. 2. Both funnel plots indicate a significant degree of
kew and graphic paucity which indicates the potential for a high degree
f publication bias. 
ooled prevalence analyses 
wnership 
The pooled prevalence for ownership at any time ( Fig. 2 ) indicated a
roportion of 57% (CI 47-67%) and a heterogeneity score of 98%. Two
dditional subgroup analyses were also conducted to provide a more
uanced picture of ownership and investigate possible rationales for
bserved heterogeneity: ownership at time of interview, termed here
current ownership’, and ‘ownership within the past 12 months’ were
reated to compare with overall pooled ownership at any time. A pooled
revalence of 43% (CI 16-72%) was observed for current ownership
three papers, Supplementary Fig. 3), compared to a pooled prevalence
f 52% (CI 40-65%) for ownership within the preceding 12 months (six
apers, Supplementary Fig. 4). 
arriage 
Pooled prevalence observed for those studies within the carriage
nalysis was 20% (CI 12-31%), with a heterogeneity score of 96%
 Fig. 3 ). To evaluate whether the measure ‘carriage on the day of in-
erview’ may act as a confounding factor, a subgroup analysis was con-
ucted which excluded those papers using this ( McDonald et al., 2020 ,
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l  ealth Protection Scotland, 2019 ). Results indicated a slightly higher
ooled carriage prevalence of 28% (CI 10-50%), with a heterogeneity
core of 97% (Supplementary Fig. 5). 
ithin study comparison – ownership and carriage 
A within subject comparison was conducted in order to directly com-
are the ownership and carriage levels of those studies which report
oth measures. In studies which reported these, ownership levels were
igher than carriage rates, similar to the trend observed in the overall
ooled estimates. 
iscussion 
Meta-analysis of the available literature found that ownership of
HN among PWUD was moderate ( > 50% in all analyses), whilst ob-
erved carriage rates were generally low (range 20-28%). This is the
rst study to attempt a comprehensive review of ownership and car-
iage rates of THN. The ability to evaluate pooled prevalence for both
wnership and carriage of THN is important as this addresses a key com-
onent of the naloxone care cascade; that of ensuring the availability
nd accessibility of naloxone when needed ( Tobin et al., 2018 ). 
Ownership as a measure remains important in assessing accessibility,
n addition to measuring carriage, because it incorporates those PWUD
ho have a personal supply of naloxone but who do not report regu-
ar carriage. In light of these findings, our recommendation for future
esearch is the standardised use of the measure ‘current ownership’, by
sking the question ‘Do you currently own a naloxone kit?’. Using cur-
ent ownership as a measure gives the most accurate picture of up-to-
ate personal supply prevalence. Future research should also include se-
ial surveillance studies to allow a better assessment of trends of nalox-
ne ownership in order to influence strategic planning needs and im-
rovement of THN provision. 
There are a variety of barriers to carriage which apply, in addition
o those for ownership. These include aspects of product design (e.g.
ulky packaging) which may impede portability; stigma or identifica-
ion as a person who uses drugs as a result of THN carriage; and po-
ice perceptions or criminal repercussions if THN is perceived to be
rug-related paraphernalia. These are all issues which can act as bar-
iers to carriage specifically, on top of ownership ( Bessen et al., 2019 ;
ayton et al., 2019 ; Lopez Gaston et al., 2009 ; Khatiwoda et al., 2018 ;
cAuley et al., 2016 ; Tobin et al., 2018 ). Primary drug use occur-
ing within the home may also negatively influence carriage of THN,
ith the perception that it is sufficient to have THN within the home
 Strang et al., 1999 ). However, peer administration for another individ-
al is much more likely to be required in an overdose situation than self-
dministration, therefore access for one’s peers outside the home also
eeds to be addressed. In addition to this, there is a recognised increased
isk of overdose for those PWUD injecting in public spaces, therefore
arriage of THN by them, and for use on another’s behalf, are impor-
ant reasons to increase prevalence more widely ( Trayner et al., 2020 ).
oreover, services must ensure that the importance of regular carriage
s conveyed when distributing THN to PWUD for these reasons. It is im-
ortant that these additional barriers to carriage are addressed if rates
re to be improved. Future research is therefore needed on issues such
s optimised product design in consultation with PWUD, and on factors
hich PWUD themselves feel would increase engagement and likelihood
f carriage. 
The rationale for a research focus on ownership and carriage is due
o the importance of these in ensuring the presence of THN during
verdose. As constructs these are relevant because both ownership and
arriage must be adopted in order for THN to become available when
eeded. If people do not own naloxone they cannot carry it. If people
o not carry it they are less likely to have access to it when needed
nd will not have access to it in all situations. In light of this, and the7 esults of this analysis, the importance of Tobin et al.’s (2018) nalox-
ne cascade is evident. Of the five pillars proposed, we have focused on
hat they would term ‘access’ and ‘possession’, in order to assess preva-
ence of ownership and carriage. The rationale for use of the cascade
s clear; in order to universally optimise provision and use of naloxone,
e must first be able to identify and optimise each pillar. The World
ealth Organisation and UNODC in 2016 launched the ‘Stop Overdose
afely’ (SOS) initiative which proposed, as part of a multi-site study,
 90% target for suitable groups to receive overdose risk and manage-
ent training ( WHO, 2016 ). In turn it was recommended that 90% of
hose receiving training were supplied with THN, with a further target
f ensuring 90% of this group should regularly carry or maintain easy
ccess to THN. Whilst the study is currently conducted in Kazakhstan,
yrgyzstan, Tajikistan, and Ukraine, there is no reason why these tar-
ets should not be applied internationally to optimise THN provision
nd use, particularly given the current opioid crisis (WHO 2016). These
ecommendations remain considerably higher than the ownership and
arriage prevalence observed within our study. Our analysis has con-
rmed that prevalence of THN ownership and carriage within the pub-
ished literature are much lower than might be anticipated after almost
5 years of advocacy and should therefore be addressed as a matter of
rgency. 
There are clear implications of this work for policy makers and prac-
itioners. Whilst there is sufficient awareness of naloxone to promote
wnership, there are still insufficient levels of carriage to promote ac-
ess when required. As such, the aforementioned barriers towards car-
iage all require to be addressed. Access to naloxone can and should
e widened to include as yet untapped services which are known to be
ighly utilised by PWUD, including GP or family practitioner services,
cute and general medical care and emergency department provision,
one of which have so far been optimised. Services external to formal
ealthcare provision should also be at the forefront of THN provision,
uch as housing and social care services. In light of the COVID-19 pan-
emic, widening of access is needed given the relative decrease in face-
o-face support and the concurrent increased risk to PWUD. Novel meth-
ds of distribution including postal THN distribution and online train-
ng, which work around COVID-19 restrictions, should also be used and
dvertised widely in all forums accessed by PWUD. 
The current evidence on prevalence of naloxone ownership and car-
iage is negatively affected by underpowered studies and a lack of con-
istency in definitions and measurements. The authors recommend the
se of the term ‘carriage’ when referring to keeping THN on one’s per-
on, in contrast to other terms such as possession, because it directly
efers to ‘carrying’ naloxone, rather than allowing inadvertent overlap
ith ownership of a personal supply. The authors also recommend the
se of frequency breakdowns as opposed to other terms such as ‘regular’
arriage which are vague and open to interpretation. Frequency break-
owns of carriage were only undertaken by two relevant studies in this
nalysis ( Dayton et al., 2019 ; Khatiwoda et al., 2018 ). Breakdowns al-
ow more detailed information to be extrapolated, including total car-
iage prevalence, carriage frequency, and total ownership (as long as
he question posed ensures that ‘never’ carry solely includes those who
o currently own naloxone). This study has shown that more clarity in
efinition and use of terms is needed to ensure that adequately homoge-
ous, and therefore increasingly meaningful comparisons, can be made
etween research studies. Ensuring this clarity would require wider in-
ernational communication and recognition of the importance of adher-
nce to standardised methods and measures in quantitative social re-
earch. By doing so it would be possible to extrapolate wider outcomes
ore easily from research and allow a greater definitive impact. 
More broadly, the limitations in the wider availability of data meant
hat further detailed subgroup analyses were not possible with too few
apers available for a sufficiently powered analysis (i.e. < 3 papers).
dditionally, given the limited number of studies available outside of
he US and UK, there is a concern that the pooled findings here may
ack generalisability to other countries. Despite the lack of data, our
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ooled estimates provide the first insights of the differences which ex-
st in naloxone ownership and carriage across studies. These highlight
hat there may be sub-optimal THN ownership and carriage across all
ountries surveyed which potentially indicates the need for a more ur-
ent and focused international response to optimise overdose prevention
hrough THN. Future research in this area should ultimately facilitate
eta-analysis which allows for sufficiently powered regional analyses
.g. by country/continent. 
Specific limitations of this review and meta-analysis include a high
egree of heterogeneity ( > 95%) which is likely to be linked to the vari-
tion in measures utilised by papers, as well as differing sampling pop-
lations (e.g. MAT clinics versus street-based outreach). The high het-
rogeneity seen in the pooled estimates, and the reduced number of ap-
ropriate studies, meant that, at times, wide confidence intervals . This
imits the utility of pooled prevalence in our analyses. In addition, the
kew of sampling in some studies towards treatment facilities (e.g. MAT
linics) may also increase the likelihood that higher numbers of respon-
ents are well engaged in treatment or harm reduction and therefore
re more likely to own naloxone. This is a potential confounding fac-
or. Despite our attempts to access grey literature, there is a degree of
eporting bias present which is likely to skew overall prevalence esti-
ates. This may be compounded by the fact that all studies found and
ncluded were English language studies. 
Difficulties lay in deducing exact sampling methods or popula-
ions of some studies. It is therefore impossible to say that there was
o overlap between community-based harm reduction agencies and
treet-based outreach sampling. Additionally, where respondent driven
ampling is used, it is challenging to identify the population char-
cteristics/demographics this may have incorporated. Use of respon-
ent driven sampling also has the potential to skew towards groups
f individuals who share common characteristics, although statisti-
al analyses were undertaken to address this within some studies
 Dayton et al., 2019 ). Certain studies (e.g. Banta-Green et al., 2020 )
ndertook convenience sampling within Injection Equipment Provision
IEP) services which is likely to have oversampled people who inject,
s opposed to those who use substances through other routes. The vari-
bility of time period in relation to drug use status is also a factor to
onsider. Some studies stipulated more recent drug use (30 days, four
eeks, three months, six months), whereas others may have included
hose who have formerly used (e.g. ‘ever injectors’, use in the past 12
onths, or not inquiring as to current drug taking status). In light of
his, most study populations were therefore mixed between both cur-
ent and former PWUD. It is possible that ownership/carriage rates may
ary between current and former PWUD, however, we were unable to
ssess this based on the available data. 
onclusions 
Understanding naloxone ownership and carriage globally is ham-
ered by limited evidence and heterogeneity across studies. The avail-
ble data suggests that ownership and carriage of naloxone remains far
hort of optimal levels, with moderate levels of ownership but low lev-
ls of carriage. Standardised classification of measurement in future re-
earch would enable more effective monitoring and comparison of the
mpact of initiatives to expand ownership and carriage globally. Our rec-
mmendations include use of ‘current ownership’ as a measure of own-
rship, and carriage frequencies in measurement of carriage prevalence.
urthermore, services must ensure going forward that the importance of
egular carriage of naloxone is always emphasised. 
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